InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Wei Lin, Directeur Médical. Director active across 3 companies, notably Erasca, Inc.. Aggregated, 12 filings have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €532k. Activity tracked since 1 February 2022. The latest transaction was disclosed on 17 March 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Wei Lin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
12 of 12 declarations
About Wei Lin
Wei Lin is Chief Medical Officer and appears in 12 filings. Across the 12 sampled filings, the transactions are sales for EUR 532181, with the modal transaction nature listed as Attribution, between 2022-02-03 and 2026-03-19, mainly at Revolution Medicines, Inc. and Erasca, Inc.
